Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -69,995 | -26,488 |
| Accounts payable and accrued liabilities | -122 | 646 |
| Other Working Capital | -4,533 | 732 |
| Other Operating Activity | 3,048 | 1,422 |
| Operating Cash Flow | $-71,602 | $-23,688 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -143,852 | N/A |
| PPE Investments | -24 | N/A |
| Sale Of Investment | 25,018 | N/A |
| Investing Cash Flow | $-118,858 | $N/A |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | N/A | 8,507 |
| Common Stock Issued | 156 | N/A |
| Other Financing Activity | 158,986 | 51,969 |
| Financing Cash Flow | $159,142 | $60,476 |
| Beginning Cash Position | 53,084 | 16,296 |
| End Cash Position | 21,766 | 53,084 |
| Net Cash Flow | $-31,318 | $36,788 |
| Free Cash Flow | ||
| Operating Cash Flow | -71,602 | -23,688 |
| Capital Expenditure | -24 | N/A |
| Free Cash Flow | -71,626 | -23,688 |